Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 46018

1.

Rationale and design of the RT-AF study: Combination of Rivaroxaban and Ticagrelor in Patients with Atrial Fibrillation and Coronary Artery Disease undergoing Percutaneous Coronary Intervention.

Gao F, Shen H, Wang ZJ, Yang SW, Liu XL, Zhou YJ.

Contemp Clin Trials. 2015 May 20. pii: S1551-7144(15)30011-2. doi: 10.1016/j.cct.2015.05.012. [Epub ahead of print]

PMID:
26003433
2.

Rhabdomyolysis precipitated by possible interaction of ticagrelor with high-dose atorvastatin.

Kido K, Wheeler MB, Seratnahaei A, Bailey A, Bain JA.

J Am Pharm Assoc (2003). 2015 May 1;55(3):320-323. doi: 10.1331/JAPhA.2015.14151.

PMID:
26003161
3.

Aortic Valve Cusps Decalcification Complicated by an Embolic Myocardial Infarction Treated by Transradial Intracoronary Embolectomy.

Medda M, Casilli F, Ghommidh EM, Bande M, Inglese L.

JACC Cardiovasc Interv. 2015 May 9. pii: S1936-8798(15)00557-9. doi: 10.1016/j.jcin.2015.02.017. [Epub ahead of print] No abstract available.

PMID:
26003027
4.

Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.

Kawamoto H, Panoulas VF, Sato K, Miyazaki T, Naganuma T, Sticchi A, Figini F, Latib A, Chieffo A, Carlino M, Montorfano M, Colombo A.

JACC Cardiovasc Interv. 2015 May 9. pii: S1936-8798(15)00487-2. doi: 10.1016/j.jcin.2015.02.011. [Epub ahead of print]

PMID:
26003020
5.

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II).

Sen H, Lam MK, Löwik MM, Danse PW, Jessurun GA, van Houwelingen KG, Anthonio RL, Tjon Joe Gin RM, Hautvast RW, Louwerenburg JH, de Man FH, Stoel MG, van der Heijden LC, Linssen GC, IJzerman MJ, Tandjung K, Doggen CJ, von Birgelen C.

JACC Cardiovasc Interv. 2015 May 9. pii: S1936-8798(15)00553-1. doi: 10.1016/j.jcin.2015.01.033. [Epub ahead of print]

PMID:
26003019
6.

Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).

Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini A; CANARY Investigators.

JACC Cardiovasc Interv. 2015 May 9. pii: S1936-8798(15)00493-8. doi: 10.1016/j.jcin.2015.01.032. [Epub ahead of print]

PMID:
26003018
7.

Single String Technique for Coronary Bifurcation Stenting: Detailed Technical Evaluation and Feasibility Analysis.

G Toth G, Pyxaras S, Mortier P, De Vroey F, Di Gioia G, Adjedj J, Pellicano M, Ferrara A, De Schryver T, Van Hoorebeke L, Verhegghe B, Barbato E, De Bruyne B, De Beule M, Wijns W.

JACC Cardiovasc Interv. 2015 May 9. pii: S1936-8798(15)00561-0. doi: 10.1016/j.jcin.2015.01.037. [Epub ahead of print]

PMID:
26003016
8.

O2 for STEMI: Still Up in the Air.

Nedeljkovic ZS, Jacobs AK.

Circulation. 2015 May 22. pii: CIRCULATIONAHA.115.017072. [Epub ahead of print]

PMID:
26002888
9.

Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease.

Ebisawa S, Kurita T, Tanaka N, Nasu K, Kimura M, Ito T, Kinoshita Y, Tsuchikane E, Terashima M, Suzuki T.

Cardiovasc Interv Ther. 2015 May 23. [Epub ahead of print]

PMID:
26001976
10.

Comparison of Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusion Using Everolimus- Versus Sirolimus- Versus Paclitaxel-Eluting Stents (from the Korean National Registry of Chronic Total Occlusion Intervention).

Lee MH, Lee JM, Kang SH, Yoon CH, Jang Y, Yu CW, Park HS, Lee SH, Hur SH, Kim MH, Rha SW, Gwon HC, Chae IH, Kim HS.

Am J Cardiol. 2015 Apr 16. pii: S0002-9149(15)01103-0. doi: 10.1016/j.amjcard.2015.04.010. [Epub ahead of print]

PMID:
26001819
11.

What is the best anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction?

Gurbel PA, Navarese EP, Tantry US.

Pol Arch Med Wewn. 2015 May 22. pii: AOP_15_048. [Epub ahead of print]

12.

Successful percutaneous coronary intervention for multivessel stenosis complicated by a huge coronary artery fistula with the combined physiology and intracoronary anatomy techniques.

Ouyang F, Chen M, Yi T, Wu M, Peng H, Huang H, Huang H, Zhou S.

Int J Cardiol. 2015 May 8;192:70-71. doi: 10.1016/j.ijcard.2015.05.026. [Epub ahead of print] No abstract available.

PMID:
26000465
13.

Association between Platelet-to-Lymphocyte Ratio and Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Demircelik MB, Kurtul A, Ocek H, Cakmak M, Ureyen C, Eryonucu B.

Cardiorenal Med. 2015 Apr;5(2):96-104. doi: 10.1159/000371496. Epub 2015 Feb 7.

PMID:
25999958
14.

The hypercoagulable profile of patients with stent thrombosis.

Loeffen R, Godschalk TC, van Oerle R, Spronk HM, Hackeng CM, Ten Berg JM, Ten Cate H.

Heart. 2015 May 21. pii: heartjnl-2014-306685. doi: 10.1136/heartjnl-2014-306685. [Epub ahead of print]

15.

Experience and accuracy can result in parity of outcomes following one or two stents for left main stem bifurcation disease.

Colombo A, Ruparelia N.

Catheter Cardiovasc Interv. 2015 Jun;85(7):1139-40. doi: 10.1002/ccd.25972.

PMID:
25999274
16.

Myocardial Bridging: An Up-to-Date Review.

Lee MS, Chen CH.

J Invasive Cardiol. 2015 May 15. pii: JIC2015515-4. [Epub ahead of print] Review.

PMID:
25999138
17.

Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.

Chanin JM, Yang DC, Haider MA, Swaminathan RV, Kim LK, Charitakis K, Tanoue M, Minutello RM, Gade CL, Singh HS, Bergman G, Wong SC, Feldman DN.

J Invasive Cardiol. 2015 May 15. pii: JIC2015515-2. [Epub ahead of print]

PMID:
25999136
18.

Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.

Gargiulo G, Longo G, Capodanno D, Francaviglia B, Capranzano P, Tamburino C.

JACC Cardiovasc Interv. 2015 May;8(6):e95-7. doi: 10.1016/j.jcin.2014.12.236. No abstract available.

PMID:
25999117
19.

Blood glucose variability: a new metric for interventional cardiology?

Farkouh ME.

JACC Cardiovasc Interv. 2015 May;8(6):812-3. doi: 10.1016/j.jcin.2015.01.021. No abstract available.

PMID:
25999103
20.

Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.

Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y, Sugiyama D, Nakagawa M, Hariki H, Inoue T, Osue T, Taniguchi Y, Iwasaki M, Nishio R, Kinutani H, Konishi A, Hiranuma N, Takahashi H, Terashita D, Hirata K.

JACC Cardiovasc Interv. 2015 May;8(6):800-11. doi: 10.1016/j.jcin.2014.11.025.

PMID:
25999102
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk